Impact of Protein Source and Polyphenol Complexation in Protein Bars on Metabolic Health
POLYPRO
Impact of Consuming Protein and Polyphenol Bars on Metabolic Health
2 other identifiers
interventional
72
1 country
1
Brief Summary
The goal of this clinical trial is to learn if pulse (pea) protein works similar to animal (whey) protein in protein bars consumed by healthy adults. The main questions it aims to answer are: What are the differences in taste and tolerance profiles between pea and whey proteins? What metabolic and immune changes do participants experience while eating them? What gastrointestinal microbiome shifts can be observed in these participants? How incorporation and complexation of polyphenols with these proteins changes the study outcomes? Participants will: Consume 1 protein bar with whey protein, pea protein, pea protein with complexed polyphenols, or pea protein with free polyphenols every day for 2 months. Visit the study site at baseline and end of study for checkups and tests. Fill dietary, food acceptance, gastrointestinal tolerance, and global health questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 8, 2025
CompletedFirst Submitted
Initial submission to the registry
March 5, 2026
CompletedFirst Posted
Study publicly available on registry
March 23, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedMarch 23, 2026
February 1, 2026
4 months
March 5, 2026
March 19, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Taste
Participants will report taste of the protein bars using a 9-point hedonic scale scored from 1 (dislike extremely) to 9 (like extremely) in a Food Acceptance Questionnaire (FAQ)
At baseline and after 2 months (end of study)
Gastrointestinal tolerance
Gastrointestinal tolerance will be assessed using the Gastrointestinal Tolerability Questionnaire (GTQ) scored on the scale of 0 (absent), 1 (mild), 2 (moderate), or 3 (severe)
At baseline and after 2 months (end of study)
Secondary Outcomes (7)
Perceived health
At baseline and after 2 months (end of study)
Fasting insulin
At baseline and after 2 months (end of study)
Fasting glucose
At baseline and after 2 months (end of study)
Glycosylated HbA1C
At baseline and after 2 months (end of study)
triglycerides
At baseline and after 2 months (end of study)
- +2 more secondary outcomes
Other Outcomes (2)
Immune activation of PMBC cells
At baseline and after 2 months (end of study)
Gastrointestinal microbiome profiles
At baseline and after 2 months (end of study)
Study Arms (4)
Whey protein bar
ACTIVE COMPARATORWhey protein bar
Pea protein bar
EXPERIMENTALPea protein bar
Pea protein complexed with polyphenols bar
EXPERIMENTALPea proteins and complexed with blackcurrant polyphenols as a single ingredient
Pea protein with free polyphenols
EXPERIMENTALPea proteins and blackcurrant polyphenols are two independent ingredients
Interventions
Pea protein with complexed polyphenols bar
Pea protein with free polyphenols bar
Eligibility Criteria
You may qualify if:
- both men and women between the ages of 18-64 years;
- body mass index of 25 and higher;
- generally healthy and without a clinically significant condition (diabetes, infectious disease, or cancer);
- participants must not be pregnant or nursing;
- participants must not be a tobacco user; and
- history of allergies or intolerance to protein bar ingredients.
You may not qualify if:
- body mass index lower than 25;
- pregnancy or nursing;
- use of blood sugar lowering medications such as metformin, semaglutide, or insulin;
- use of dietary supplements with polyphenols;
- history of allergies or intolerance to protein bar ingredients;
- noncompliance with the study protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Plants for Human Health Institute
Kannapolis, North Carolina, 28081, United States
Related Publications (1)
https://doi.org/10.1111/jfpe.70121
BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Pharmacogenomics
Study Record Dates
First Submitted
March 5, 2026
First Posted
March 23, 2026
Study Start
May 1, 2025
Primary Completion
September 8, 2025
Study Completion
April 1, 2026
Last Updated
March 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share